Synapse

← JACC Asia

Papers in JACC Asia

Page 17 · newest first

  1. Inherited Thrombophilia in Chinese CTEPH PatientsJACC Asia · 2022
  2. Pulmonary Arterial Hypertension Management in AsiaJACC Asia · 2022
  3. The Match of Electrocardiogram and Artificial Intelligence Confers an Opportunity for Pulmonary Hypertension ScreeningJACC Asia · 2022
  4. Incidence, Prediction, and Outcomes of Major Bleeding After Percutaneous Coronary Intervention in Chinese PatientsJACC Asia · 2022
  5. Soluble Corin Predicts the Risk of Cardiovascular DiseaseJACC Asia · 2022
  6. Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial FibrillationJACC Asia · 2022
  7. In-Hospital Mortality of Patients With Acute Type A Aortic Dissection Hospitalized on Weekends Versus WeekdaysJACC Asia · 2022
  8. ABC PathwayJACC Asia · 2022
  9. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary InterventionJACC Asia · 2022
  10. Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary RevascularizationJACC Asia · 2022
  11. Residual Inflammatory Risk After Percutaneous Coronary InterventionJACC Asia · 2022
  12. Longitudinal Quantitative Assessment of Coronary Atherosclerotic Plaque Burden Related to Serum Hemoglobin LevelsJACC Asia · 2022
  13. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in ChinaJACC Asia · 2022
  14. Diabetes Mellitus With Coronary Artery DiseaseJACC Asia · 2022
  15. Comparison Between Bicuspid and Tricuspid Aortic RegurgitationJACC Asia · 2022
  16. Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection FractionJACC Asia · 2022
  17. Differences in Plaque Characteristics and Myocardial MassJACC Asia · 2022
  18. Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HFENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2022
  19. Percutaneous Coronary Intervention for Left Main Coronary Artery DiseaseJACC Asia · 2022
  20. Is Lower Better?JACC Asia · 2022
  21. Influence of Baseline HbA1c and Antiplatelet Therapy on 1-Year Vein Graft OutcomeJACC Asia · 2022
  22. Comparison of Contemporary Drug-Eluting Stents in Patients Undergoing Complex High-Risk Indicated ProceduresJACC Asia · 2022
  23. Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent RestenosisJACC Asia · 2022
  24. Impact of Frailty on Postoperative Dysphagia in Patients Undergoing Elective Cardiovascular SurgeryJACC Asia · 2022
  25. Status of Cardiovascular Health in Chinese Children and AdolescentsJACC Asia · 2022
  26. Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian PopulationsJACC Asia · 2022
  27. Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial FibrillationJACC Asia · 2022
  28. Which Renal Function Equation Should Be Used for Prescribing DOACs in Patients With Atrial Fibrillation?JACC Asia · 2022
  29. Gauging ASCVD Risk, Does Race Matter?JACC Asia · 2022
  30. Prognostic Impact of Echocardiographic Congestion Grade in HFpEF With and Without Atrial FibrillationJACC Asia · 2022
  31. Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in ChinaJACC Asia · 2022
  32. Is There Still a Sex Difference According to the Coronary Revascularization Strategy?JACC Asia · 2022
  33. Transcatheter Aortic Valve Replacement in AsiaJACC Asia · 2021
  34. Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation PredictionJACC Asia · 2021
  35. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy FindingsJACC Asia · 2021
  36. Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific RegionJACC Asia · 2021
  37. Improvements in Coronary Stent Design Translate to Better Real-World OutcomesJACC Asia · 2021
  38. Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart FailureJACC Asia · 2021
  39. Predicting the Future With Wearable TechnologyJACC Asia · 2021
  40. The PCSK9 ProblemJACC Asia · 2021
  41. Clinical Diagnosis of Cardiac Sarcoidosis Improves Treatment Effectiveness and Unmasks Isolated Cardiac SarcoidosisJACC Asia · 2021
  42. Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting StentsJACC Asia · 2021
  43. Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese SubjectsJACC Asia · 2021
  44. Prognostic Value of Sex After Revascularization for Left Main Coronary DiseaseJACC Asia · 2021
  45. Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents ImplantationJACC Asia · 2021
  46. Newer-Generation Drug-Eluting Stents in Patients Undergoing Complex Percutaneous Coronary InterventionJACC Asia · 2021
  47. A Novel Prediction Model of Acute Kidney Injury Based on Combined Blood Variables in STEMIJACC Asia · 2021
  48. Lowering the Recommended Maximal Wall Thickness Threshold Improves Diagnostic Sensitivity in Asians With Hypertrophic CardiomyopathySHILAP Revista de lepidopterología · 2021
  49. Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes MellitusJACC Asia · 2021
  50. The Use of Machine Learning for the Care of Hypertension and Heart FailureJACC Asia · 2021